Effects of clofibrate and dextrothyroxine singly and in combination on serum lipids. 1966

M M Best, and C H Duncan

UI MeSH Term Description Entries
D006949 Hyperlipidemias Conditions with excess LIPIDS in the blood. Hyperlipemia,Hyperlipidemia,Lipemia,Lipidemia,Hyperlipemias,Lipemias,Lipidemias
D008074 Lipoproteins Lipid-protein complexes involved in the transportation and metabolism of lipids in the body. They are spherical particles consisting of a hydrophobic core of TRIGLYCERIDES and CHOLESTEROL ESTERS surrounded by a layer of hydrophilic free CHOLESTEROL; PHOSPHOLIPIDS; and APOLIPOPROTEINS. Lipoproteins are classified by their varying buoyant density and sizes. Circulating Lipoproteins,Lipoprotein,Lipoproteins, Circulating
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D001797 Blood Protein Electrophoresis Electrophoresis applied to BLOOD PROTEINS. Hemoglobin Electrophoresis,Electrophoresis, Blood Protein,Electrophoresis, Hemoglobin,Protein Electrophoresis, Blood
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D003918 Dextrothyroxine The dextrorotary isomer of the synthetic THYROXINE. D-Thyroxine,Dextrothyroxine Sodium,Choloxin,D-T4 Thyroid Hormone,Sodium Dextrothyroxine,D Thyroxine

Related Publications

M M Best, and C H Duncan
May 1969, Revista medica de Chile,
M M Best, and C H Duncan
February 1975, Clinical pharmacology and therapeutics,
M M Best, and C H Duncan
January 1967, Archives of internal medicine,
M M Best, and C H Duncan
March 1967, Medizinische Klinik,
M M Best, and C H Duncan
May 1969, Circulation,
M M Best, and C H Duncan
February 1980, Orvosi hetilap,
M M Best, and C H Duncan
January 1972, Clinica chimica acta; international journal of clinical chemistry,
M M Best, and C H Duncan
April 1968, Current therapeutic research, clinical and experimental,
M M Best, and C H Duncan
October 1967, British medical journal,
Copied contents to your clipboard!